LianBio is a biotechnology company focused on bringing paradigm-shifting medicines to patients through partnerships that provide access to the best science-driven therapeutic discoveries.
Location: China, Shanghai
Total raised: $635M
Investors 4
| Date | Name | Website |
| 21.02.2021 | Logos Capi... | logoscapit... |
| - | RA Capital... | racap.com |
| - | Perceptive... | perceptive... |
| 02.11.2022 | Xontogeny | xontogeny.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.11.2021 | IPO | $325M | - |
| 29.10.2020 | - | $310M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 12.05.2023 | LianBio Announces Marketing Approval of CAMZYOS® (mavacamten... | SHANGHAI, CHINA, and PRINCETON, N. J., USA – Media OutReach – 12 May 2023 – LianBio (Nasdaq: LIAN), ... | africanews... |
| 07.09.2022 | NANOBIOTIX与联拓生物宣布，用于评估NBTXR3治疗头颈癌的NANORAY-312 III期试验在亚洲完成首位患... | 针对Nanobiotix治疗头颈癌的关键性III期试验,其区域启动工作按计划推进，联拓生物在亚洲完成首位患者招募此项合作继续增强联拓生物在亚洲的行业领导地位，同时，Nanobiotix将继续专注于计划... | globenewsw... |
| 01.11.2021 | China-Focused Biotech LianBio Raises $325 Million in U.S. IP... | (Bloomberg) -- Biotechnology firm LianBio raised $325 million in an initial public offering, accordi... | bloombergq... |
| 29.10.2020 | LianBio Raises $310 Million Crossover Financing | SHANGHAI & PRINCETON, N.J.--(BUSINESS WIRE)--LianBio, a Chinese company focused on bringing para... | citybizlis... |
| 29.10.2020 | LianBio Announces $310 Million Crossover Financing | - | vidaventur... |
| 29.10.2020 | LianBio : Announces $310 Million Crossover Financing | LianBio, a Chinese company focused on bringing paradigm-shifting medicines to patients in China and ... | marketscre... |